Fundraising Fox

Viracta Therapeutics

San Diego, US · Delaware corporation · 1 known investors

Biotech

Founders & leadership

JW
James WoodyExecutive
DS
David SlackExecutive

Board

IR
Ivor RoystonBoard director
PS
Patrick Soon-ShiongBoard director
RG
Richard GhalieBoard director

Investors · 1

aMoonreportedRa'ananavia Gur Roshwalb · board

Reported raises · per SEC filings

Form D private placements

$150.7M disclosed across 7 rounds · 2017–2021

▶$65MraisedMar 2021 · 26 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ivor RoystonExecutive Officer, Director
  • Richard GhalieDirector
  • Michael HuangDirector
  • Daniel ChevallardExecutive Officer
  • Roger PomerantzDirector
  • Gur RoshwalbDirector
  • Samuel MurphyDirector
Offering amount
$65M
Amount sold
$65M
First sale
Feb 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$40MraisedDec 2020 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ivor RoystonExecutive Officer, Director
  • Richard GhalieDirector
  • Michael HuangDirector
  • Daniel ChevallardExecutive Officer
  • Roger PomerantzDirector
  • Gur RoshwalbDirector
  • Samuel MurphyDirector
Offering amount
$40M
Amount sold
$40M
First sale
Nov 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$16.8MraisedNov 2019 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David SlackExecutive Officer
  • Standish FlemingDirector
  • Michael HuangDirector
  • James WoodyDirector
  • Samuel MurphyDirector
  • Richard GhalieDirector
  • Daniel ChevallardExecutive Officer
  • Barry SimonDirector
  • Ivor RoystonExecutive Officer, Director
Offering amount
$25M
Amount sold
$16.8M
First sale
Oct 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10.7MraisedFeb 2019 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Standish FlemingDirector
  • Patrick Soon-ShiongDirector
  • Ivor RoystonExecutive Officer, Director
  • James WoodyDirector
  • Richard GhalieDirector
  • David SlackExecutive Officer
  • Barry SimonDirector
Offering amount
$10.7M
Amount sold
$10.7M
First sale
Nov 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.7MraisedFeb 2019 · 25 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Patrick Soon-ShiongDirector
  • Barry SimonDirector
  • James WoodyDirector
  • Richard GhalieDirector
  • David SlackExecutive Officer
  • Standish FlemingDirector
  • Ivor RoystonExecutive Officer, Director
Offering amount
$5.7M
Amount sold
$5.7M
First sale
Jan 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.7MraisedJul 2018 · 27 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Standish FlemingDirector
  • Patrick Soon-ShiongDirector
  • Richard GhalieDirector
  • Ivor RoystonExecutive Officer, Director
  • David SlackExecutive Officer
  • Barry SimonDirector
  • James WoodyDirector
Offering amount
$8.5M
Amount sold
$2.7M
First sale
Jun 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9.9MraisedApr 2017 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ivor RoystonExecutive Officer, Director
  • Richard GhalieDirector
  • James WoodyDirector
  • Patrick Soon-ShiongDirector
  • David SlackExecutive Officer
Offering amount
$26.9M
Amount sold
$9.9M
First sale
Mar 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Viracta Therapeutics's investors?
Viracta Therapeutics's investors include aMoon.
How much funding has Viracta Therapeutics raised?
Viracta Therapeutics has disclosed $150.7M raised across 7 rounds.
Where is Viracta Therapeutics headquartered?
Viracta Therapeutics is headquartered in San Diego, US.